News Research
03/05/2021
MAbImprove reviews the most advanced anti-CoVID-19 monoclonal antibodies
Read more
News Research
22/03/2021
A MAbImprove team successful in the Gates Foundation Grand Challenge
Read more
News Research
10/02/2021
A MAbImprove team successful in the INCa-DGOS call!
Read more
Research
20/05/2015
First-in-human phase I study for SurgiMab’s molecule SGM-101 launched in Montpellier Cancer Institute.
Read more